Volpara Health Technologies Ltd
ASX:VHT
Relative Value
The Relative Value of one VHT stock under the Base Case scenario is 1.17 AUD. Compared to the current market price of 1.14 AUD, Volpara Health Technologies Ltd is Undervalued by 3%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
VHT Competitors Multiples
Volpara Health Technologies Ltd Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
NZ |
Volpara Health Technologies Ltd
ASX:VHT
|
290m AUD | 8.4 | -35.8 | -30.1 | -30.1 | ||
US |
Veeva Systems Inc
NYSE:VEEV
|
32.5B USD | 13.7 | 61.8 | 61.6 | 66.3 | ||
US |
Cerner Corp
NASDAQ:CERN
|
27.9B USD | 4.8 | 47.3 | 19.6 | 38.6 | ||
US |
Change Healthcare Inc
NASDAQ:CHNG
|
9B USD | 2.6 | -116.8 | 16.5 | 111.6 | ||
AU |
Pro Medicus Ltd
ASX:PME
|
11.9B AUD | 81.1 | 170.1 | 117 | 117 | ||
US |
Inspire Medical Systems Inc
NYSE:INSP
|
7.4B USD | 11.9 | -351 | -186.1 | -173 | ||
JP |
M3 Inc
TSE:2413
|
1.1T JPY | 4.8 | 24.1 | 12.5 | 14.1 | ||
US |
Doximity Inc
NYSE:DOCS
|
4.5B USD | 9.7 | 32.9 | 22 | 23.5 | ||
SE |
Sectra AB
STO:SECT B
|
42B SEK | 25.6 | 98.9 | -65.1 | -65.1 | ||
US |
Evolent Health Inc
NYSE:EVH
|
3.1B USD | 1.6 | -21.9 | 25.9 | 275.5 | ||
US |
Certara Inc
NASDAQ:CERT
|
2.8B USD | 7.9 | -50.9 | 46.1 | 461.9 |